SPONSOR
Beijing Suncadia Pharmaceuticals Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3, Phase 3
Beijing Suncadia Pharmaceuticals Co., Ltd is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Severe Cerebral Edema Following Large Hemispheric Infarction, Hyperlipidemia.
The trial portfolio spans Phase 2, Phase 3, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Suncadia Pharmaceuticals Co., Ltd
How many clinical trials has Beijing Suncadia Pharmaceuticals Co., Ltd sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd, of which 2 are actively recruiting participants. These trials cover conditions including Severe Cerebral Edema Following Large Hemispheric Infarction, Hyperlipidemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Suncadia Pharmaceuticals Co., Ltd research focus on?
Beijing Suncadia Pharmaceuticals Co., Ltd clinical trials span Severe Cerebral Edema Following Large Hemispheric Infarction, Hyperlipidemia. The research pipeline includes Phase 2, Phase 3, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing Suncadia Pharmaceuticals Co., Ltd clinical trial?
To participate in a Beijing Suncadia Pharmaceuticals Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Suncadia Pharmaceuticals Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Beijing Suncadia Pharmaceuticals Co., Ltd
NCT06732648 Phase 2, Phase 3
Recruiting
The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction
Severe Cerebral Edema Following Large Hemispheric Infarction
NCT07230730 Phase 3
Recruiting
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Hyperlipidemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology